Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2003
12/31/2003WO2004000830A1 Novel compounds, their use and preparation
12/31/2003WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003WO2004000807A1 Cannabinoid receptor agonists
12/31/2003WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003WO2004000785A2 Phenyloxyalkanonic acid derivatives as hppar activators
12/31/2003WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003WO2004000369A2 Method of magnetically manipulating a cell with magnetisable particles
12/31/2003WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
12/31/2003WO2004000326A1 Combination therapy wherein a serotonin reuptake inhibitor is used
12/31/2003WO2004000324A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/31/2003WO2004000322A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003WO2004000321A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003WO2004000316A1 Use of mglur5 antagonists for the treatment of gerd
12/31/2003WO2004000315A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003WO2004000312A2 Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
12/31/2003WO2004000296A1 (2s)-2amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
12/31/2003WO2004000292A1 Composition comprising stabilised choline ascorbate
12/31/2003WO2004000252A1 Protein based oral lubricant
12/31/2003WO2004000237A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003WO2004000225A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions
12/31/2003WO2004000219A2 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
12/31/2003WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
12/31/2003WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation
12/31/2003WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
12/31/2003WO2003094911B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
12/31/2003WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/31/2003WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/31/2003WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia
12/31/2003WO2003063758A3 Bicyclic cb2 cannabinoid receptor ligands
12/31/2003WO2003059269A3 Acridone inhibitors of impdh enzyme
12/31/2003WO2003055916A3 Adiponectin fragments and conjugates
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003WO2002047706A3 Selective cox-2 inhibition from plant extracts
12/31/2003WO2002047615A3 Oral compositions and use thereof
12/31/2003WO2002043578A3 Determination of risk and treatment of complications of prematurity
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2001006984A3 Small molecules useful in the treatment of inflammatory disease
12/31/2003CN2595368Y Nano glossy ganoderma and cordyceps sinensis capsule
12/31/2003CN1464788A Pharmaceutical compositions for headache, migraine, nausea and emesis
12/31/2003CN1463741A Oral disinfecting and cleaning liquid containing extract of oceanic organism
12/31/2003CN1463730A Prepared Chinese medicine for treating ulcerative stomatitis
12/31/2003CN1463729A Health care pillow containing traditional Chinese medicine
12/31/2003CN1463712A Health food additive and process for preparing same
12/31/2003CN1132837C 螺呋喃并吡啶芳烷基胺、其制法和中间体及其药物组合物和制药用途 Spiro furopyridine arylalkylamines, their preparation and intermediates and pharmaceutical compositions thereof and pharmaceutical use
12/31/2003CN1132627C Solid fermentation process of producing waxy microecological bacillus prepn
12/31/2003CN1132623C Compound Chinese medicine prepn. containing Jisongrong and Its prepn process
12/31/2003CN1132622C Medicine for treating viral hepatitis and its preparing process
12/31/2003CN1132617C Stomach-benefiting powder
12/31/2003CN1132604C Powdered medicine for treating gastroenteritis and its preparing process
12/31/2003CN1132602C Full-natural medicine for treating calculus
12/31/2003CN1132593C Mixture of white pepper and borneol and its application
12/31/2003CN1132591C Chewing tablets of pilose antler, deerhorn and deer bone and preparing process thereof
12/31/2003CN1132588C Chinese patent medicine for treating gastrosis and its preparing process
12/31/2003CA2495395A1 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
12/31/2003CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2491070A1 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003CA2489930A1 Methods and means to promote gut absorption
12/31/2003CA2489813A1 Use of thio-oxindole derivatives in treatment of hormone-related conditions
12/31/2003CA2489561A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same
12/31/2003CA2489540A1 Methods of treating and preventing colitis involving il-13 and nk-t cells
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003CA2487909A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487541A1 Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2485537A1 Novel compounds, their use and preparation
12/31/2003CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier
12/30/2003US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide;
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/30/2003US6670364 Antagonists of MCP-1 function and methods of use thereof
12/30/2003US6670360 Antiulcer, antibacterial activity against Helicobacter pylori
12/30/2003US6670359 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders
12/30/2003US6670358 Substituted thioacetamides
12/30/2003US6670343 Methanebisphosphonic acid derivative, or a hydrate
12/30/2003US6670342 Method of treating hepatitis delta virus infection
12/30/2003US6670341 Phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2293621C 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists
12/30/2003CA2291732C A salt (r)-3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxaminde hydrogen (2r,3r)-tartrate
12/30/2003CA2221356C Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
1 ... 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 ... 1258